Publications

Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and NK Cell Function.

WAGSTAFFE, HR; PICKERING, H; HOUGHTON, J; MOONEY, JP; WOLF, A-S; Prevatt, N; BEHRENS, RH; HOLLAND, MJ; RILEY, EM; GOODIER, MR;

2019

Journal of immunology, (2019).203 6 10.4049/jimmunol.1801648.

Pneumococcal carriage in children in Ulaanbaatar, Mongolia before and one year after the introduction of the 13-valent pneumococcal conjugate vaccine.

Von Mollendorf, C; Dunne, EM; La Vincente, S; Ulziibayar, M; Suuri, B; Luvsantseren, D; Narangerel, D; Ortika, BD; Pell, CL; Nation, ML; Alamrousi, A; Hinds, J; Demberelsuren, S; Nguyen, C; Mungun, T; MULHOLLAND, EK; Satzke, C;

2019

VACCINE, (2019).37 30 10.1016/j.vaccine.2019.05.078.

Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.

ODUTOLA, A; Ota, MO C; ANTONIO, M; Ogundare, EO; Saidu, Y; Owiafe, PK; Worwui, A; Idoko, OT; Owolabi, O; KAMPMANN, B; GREENWOOD, BM; Alderson, M; Traskine, M; Swinnen, K; Verlant, V; Dobbelaere, K; Borys, D;

2019

Vaccine, (2019).37 19 10.1016/j.vaccine.2019.03.033.

Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.

Sturkenboom, M; Bahri, P; Chiucchiuini, A; Grove Krause, T; Hahné, S; Khromava, A; Kokki, M; Kramarz, P; Kurz, X; LARSON, HJ; De Lusignan, S; Mahy, P; Torcel-Pagnon, L; Titievsky, L; Bauchau, V; ADVANCE consortium,;

2019

Vaccine, (2019).38 Sup, 10.1016/j.vaccine.2019.07.081.

Opportunities to improve vaccination coverage in a country with a fledgling health system: Findings from an assessment of missed opportunities for vaccination among health center attendees-Timor Leste, 2016.

Li, AJ; Peiris, TS R; SANDERSON, C; Nic Lochlainn, L; Mausiry, M; Da Silva, RB J B M; Ogbuanu, IU;

2019

Vaccine, (2019).37 31 10.1016/j.vaccine.2019.06.041.

Impact of demographic disparities in social distancing and vaccination on influenza epidemics in urban and rural regions of the United States.

Singh, M; Sarkhel, P; Kang, GJ; Marathe, A; Boyle, K; Murray-Tuite, P; ABBAS, KM; Swarup, S;

2019

BMC INFECTIOUS DISEASES, (2019).19 1 10.1186/s12879-019-3703-2.

The global impact and cost-effectiveness of a melioidosis vaccine.

Luangasanatip, N; FLASCHE, S; DANCE, DA B; Limmathurotsakul, D; Currie, BJ; Mukhopadhyay, C; Atkins, T; Titball, R; JIT, M;